Improving treatment for multi-drug resistant tuberculosis patients: lessons from Shandong Province, China

Findings from a study to identify the barriers to case management from the experiences of MDR-TB patients and providers

From:
Department for International Development
Published
1 March 2016
Country:
China
Document Type:
Briefing
Theme:
Health
Authors:
COMDIS

Abstract

China has almost one fifth of all the world’s multi-drug resistant-TB (MDR-TB) cases and the second highest number of TB cases in the world. Over the past 10 years, China has taken some important steps to improve MDR-TB control

This policy brief sets out findings from a study to identify the barriers to case management from the experiences of multi-drug resistant-TB (MDR-TB) patients and providers during 3 periods:

  1. identification of suspected cases
  2. MDR-TB diagnosis (sputum culture and drug sensitivity tests)
  3. MDR-TB treatment.

This research is supported by the Department for International Development’s COMDIS-HSD Programme which is led by the University of Leeds

Citation

COMDIS. Improving treatment for multi-drug resistant tuberculosis patients: lessons from Shandong Province, China, COMDIS-HSD Policy Brief (2016), 2p

Improving treatment for multi-drug resistant tuberculosis patients: lessons from Shandong Province, China

Updates to this page

Published 1 March 2016
Contents